Cite
HARVARD Citation
Cheah, P. et al. (n.d.). Long-term therapeutic efficacy of intravenous AAV-mediated hamartin replacement in mouse model of tuberous sclerosis type 1. IBRO reports. pp. S504-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cheah, P. et al. (n.d.). Long-term therapeutic efficacy of intravenous AAV-mediated hamartin replacement in mouse model of tuberous sclerosis type 1. IBRO reports. pp. S504-. [Online].